Fig. 2From: Development of neoplasms in pediatric patients with rheumatic disease exposed to anti-tumor necrosis factor therapies: a single Centre retrospective studyHead CT with contrast of a 16-year-old male who developed a nasopharyngeal carcinoma 3.3 years after starting infliximab infusionsBack to article page